Probiotic bacteria, B.longum and L.acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients

Clinics and Research in Hepatology and Gastroenterology

Volumn 39, Issue 2, 2015, Pages 237-244

  Lee, Do Kyung ^a   Park, Jae Eun ^a   Kim, Min Ji ^a   Seo, Jae Goo ^b   Lee, Ji Hyuk ^c   Ha, Nam Joo ^a  

^a Sahmyook University   (South Korea)

^b Cellbiotech Co Ltd   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PLACEBO; PROBIOTIC AGENT;

ABDOMINAL PAIN; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG CYTOTOXICITY; DRUG EFFICACY; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; IN VITRO STUDY; INFANT; KOREAN (PEOPLE); LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS GASSERI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MALE; MTT ASSAY; NONHUMAN; PEDIOCOCCUS PENTOSACEUS; RANDOMIZED CONTROLLED TRIAL; ROTAVIRUS INFECTION; VIRAL GASTROENTERITIS; VOMITING; ADOLESCENT; ADULT; AGED; BIFIDOBACTERIUM; DIET THERAPY; GASTROENTERITIS; MIDDLE AGED; PRESCHOOL CHILD; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIFIDOBACTERIUM; CHILD; CHILD, PRESCHOOL; DIARRHEA; DOUBLE-BLIND METHOD; GASTROENTERITIS; HUMANS; LACTOBACILLUS ACIDOPHILUS; MIDDLE AGED; PROBIOTICS; ROTAVIRUS INFECTIONS; YOUNG ADULT;

EID: 84926353902     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2014.09.006     Document Type: Article

References (33)

1. Chow C.M., Leung A.K.C., Hon K. Acute gastroenteritis: from guidelines to real life. Clin Exp Gastroenterol 2010, 3:97-112.
2. Webb A., Starr M. Acute gastroenteritis in children. Aust Fam Physician 2005, 34:227-231.
3. Szajewska H., Kotowska M., Mrukowicz J.Z., Armanska M., Mikotajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001, 138:361-365.
4. Wilhelmi I., Roman E., Sanchez-Fauquier A. Viruses causing gastroenteritis. Clin Microbiol Infect 2003, 9:247-262.
5. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003, 9:565-572.
6. Rivest P., Proulx M., Lonergan G., Lebel M.H., Bedard L. Hospitalisations for gastroenteritis: the role of rotavirus. Vaccine 2004, 22:2013-2017.
7. Wu T.C., Liu H.H., Chen Y.J., Tang R.B., Hwang B.T., Yuan H.C. Comparison of clinical features of childhood norovirus and rotavirus gastroenteritis in Taiwan. J Chin Med Assoc 2008, 71:566-570.
8. Simpson E., Wittet S., Bonilla J., Gamazina K., Cooley L., Winkler J.L. Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries. BMC Public Health 2007, 7:281. 10.1186/1471-2458-7-281.
9. World Health Organization Global networks for surveillance of rotavirus gastroenteritis, 2001-2008. Wkly Epidemiol Rec 2008, 83:421-428.
10. Desselberger U., Gray J. Viral gastroenteritis. Medicine 2013, 41:700-704.
11. Moon H.H., Kim D.S., Park S.H., Kim H.M. Clinical characteristic and genotype of rotavirus infection in newborn infants. Kor J Perinatol 2012, 23:266-272.
12. Bines J.E. Rotavirus vaccines and intussusception risk. Curr Opin Gastroenterol 2005, 21:20-25.
13. Guandalini S., Pensabene L., Zikri M.A., Dias J.A., Casali L.G., Hoekstra H., et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000, 30:54-60.
14. Isolauri E. Probiotics for infectious diarrhoea. Gut 2003, 52:436-437.
15. Thibault H., Aubert-Jacquin A., Goulet O. Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr 2004, 39:147-152.
16. Kotzampassi K., Giamarellos-Bourboulis E.J. Probiotics for infectious diseases: more drugs, less dietary supplementation. Int J Antimicrob Agents 2012, 40:288-296.
17. Rautava S. Potential uses of probiotics in the neonate. Semin Fetal Neonatal Med 2007, 12:45-53.
18. Butel M.J. Probiotics, gut microbiota and health. Med Mal Infect 2014, 44:1-8.
19. Chandra R.K. Effect of Lactobacillus on the incidence and severity of acute rotavirus diarrhea in infants: a prospective placebo-controlled double-blind study. Nutr Res 2002, 22:65-69.
20. Shornikova A.V., Casas I.A., Isolauri E., Mykkänen H., Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr 1997, 24:399-404.
21. Borriello S.P., HammesWP, Holzapfel W., Marteau P., Schrezenmeir J., Vaara M., et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003, 36:775-780.
22. Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol 2001, [Appendix 3:Appendix 3B].
23. de Vrese M., Marteau P.R. Probiotics and prebiotics: effects on diarrhea. J Nutr 2007, 137. 803S-811S.
24. Muñoz J.A., Chenoll E., Casinos B., Bataller E., Ramón D., Genovés S., et al. Novel probiotic Bifidobacterium longum subsp. Infantis CECT 7210 strain active against rotavirus infections. Appl Environ Microbiol 2011, 77:8775-8783.
25. Canani R.B., Cirillo P., Terrin G., Cesarano L., Spagnuolo M.I., De Vicenzo A., et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 2007, 335:340. 10.1136/bmj.39272.581736.55.
26. Majamaa H., Isolauri E., Saxelin M., Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995, 20:333-338.
27. Mastretta E., Longo P., Laccisaglia A., Balbo L., Russo R., Mazzaccara A., et al. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 2002, 35:527-531.
28. Szajewska H1, Skórka A., Ruszczyński M., Gieruszczak-Białek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children-updated analysis of randomised controlled trials. Aliment Pharmacol Ther 2013, 38:467-476.
29. Scheier E., Aviner S. Septicemia following rotavirus gastroenteritis. Isr Med Assoc J 2013, 15:166-169.
30. Yeung C.Y., Lee H.C., Lin S.P., Fang S.B., Jiang C.B., Huang F.Y., et al. Serum cytokines in differentiating between viral and bacterial enterocolitis. Ann Trop Paediatr 2004, 24:337-343.
31. Iwasa T., Matsubayashi N. Protein-looing enteropathy associated with rotavirus infection in an infant. World J Gastroenterol 2008, 14:1630-1632.
32. Botić T., Klingberg T.D., Weingartl H., Cencič A. A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria. Int J Food Microbiol 2007, 115:227-234.
33. Colbère-Garapin F., Martin-Latil S., Blondel B., Mousson L., Pelletier I., Autret A., et al. Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria. Microbes Infect 2007, 9:1623-1631.